share_log

Wedbush Reiterates Outperform on Omega Therapeutics, Maintains $12 Price Target

Benzinga ·  Jan 5 02:57

Wedbush analyst Robert Driscoll reiterates Omega Therapeutics (NASDAQ:OMGA) with a Outperform and maintains $12 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment